Antonio Luca Bartorelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Antonio Luca Bartorelli has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Angelo Mastrangelo
IRCCS Ospedale Galeazzi-Sant’Ambrogio , Via Cristina Belgioioso 173, 20157 Milan
3 shared publicationsDaniele Andreini
IRCCS Ospedale Galeazzi-Sant’Ambrogio , Via Cristina Belgioioso 173, 20157 Milan
3 shared publications- Daniele Andreini
Department of Biomedical and Clinical Sciences, University of Milan, 20122 Milan, Italy
3 shared publications - Edoardo Conte
Department of Clinical and Imaging Cardiology-Galeazzi-Sant'Ambrogio Hospital, Milan, Italy
3 shared publications Franco Fabbiocchi
IRCCS Ospedale Galeazzi-Sant’Ambrogio , Via Cristina Belgioioso 173, 20157 Milan
3 shared publicationsGiovanni Monizzi
IRCCS Ospedale Galeazzi-Sant’Ambrogio , Via Cristina Belgioioso 173, 20157 Milan
3 shared publications
Latest Publications
- Open Access
Impact of Institutional Monthly Volume of Transcatheter Edge-to-Edge Repair Procedures for Significant Mitral Regurgitation: Evidence from the GIOTTO-VAT Study
Background and Objectives: Mitral valve transcatheter edge-to-edge repair (TEER) is a widely adopted therapeutic approach for managing significant mitral regurgitation (MR) in high-risk surgical candidates. While procedural safety and efficacy have been demonstrated, the impact of institutional expertise on outcomes remains unclear. We aimed at evaluating whether the institutional monthly volume of TEER influences short- and long-term clinical results. Materials and Methods: This analysis from the multicenter, prospective GIOTTO trial study evaluated the impact of institutional monthly volume on outcomes of TEER to remedy significant mitral regurgitation. Centers were stratified into tertiles based on monthly volumes (≤2.0 cases/month, 2.1–3.5 cases/month, >3.5 cases/month), and key clinical, echocardiographic, and procedural outcomes were analyzed. Statistical analysis was based on standard bivariate tests as well as unadjusted and multivariable adjusted Cox models. Results: A total of 2213 patients were included, stratified into tertiles based on institutional procedural volume: 645 (29.1%) patients in the first tertile, 947 (42.8%) patients in the second tertile, and 621 (28.1%) patients in the third tertile. Several baseline differences were found, with some features disfavoring less busy centers (e.g., functional class and surgical risk, both p < 0.05), and others suggesting a worse risk profile in those treated in busier institutions (e.g., frailty and history of prior mitral valve intervention, both p < 0.05). Procedural success rates were higher in busier centers (p < 0.001), and hospital stay was also shorter there (p < 0.001). Long-term follow-up (median 14 months) suggested worse outcomes in patients treated in less busy centers at unadjusted analysis (e.g., p = 0.018 for death, p = 0.015 for cardiac death, p = 0.014 for death or hospitalization for heart failure, p < 0.001 for cardiac death or hospitalization for heart failure), even if these associations proved no longer significant after multivariable adjustment, except for cardiac death or hospitalization for heart failure, which appeared significantly less common in the busiest centers (p < 0.05). Similar trends were observed when focusing on tertiles of overall center volume and when comparing for each center the first 50 cases with the following ones. Conclusions: High institutional monthly volume of TEER mitral valve repair appears to correlate with an improved procedural success rate and shorter hospitalizations. Similarly favorable results were found for long-term rates of cardiac death or hospitalization for heart failure. These findings inform on the importance of operator experience and center expertise in achieving state-of-the-art results with TEER, while confirming the usefulness of the proctoring approach when naïve centers begin a TEER program.
Open AccessImpact of Institutional Monthly Volume of Transcatheter Edge-to-Edge Repair Procedures for Significant Mitral Regurgitation: Evidence from the GIOTTO-VAT Study
Background and Objectives: Mitral valve transcatheter edge-to-edge repair (TEER) is a widely adopted therapeutic approach for managing significant mitral regurgitation (MR) in high-risk surgical candidates. While procedural safety and efficacy have been demonstrated, the impact of institutional expertise on outcomes remains unclear. We aimed at evaluating whether the institutional monthly volume of TEER influences short- and long-term clinical results. Materials and Methods: This analysis from the multicenter, prospective GIOTTO trial study evaluated the impact of institutional monthly volume on outcomes of TEER to remedy significant mitral regurgitation. Centers were stratified into tertiles based on monthly volumes (≤2.0 cases/month, 2.1–3.5 cases/month, >3.5 cases/month), and key clinical, echocardiographic, and procedural outcomes were analyzed. Statistical analysis was based on standard bivariate tests as well as unadjusted and multivariable adjusted Cox models. Results: A total of 2213 patients were included, stratified into tertiles based on institutional procedural volume: 645 (29.1%) patients in the first tertile, 947 (42.8%) patients in the second tertile, and 621 (28.1%) patients in the third tertile. Several baseline differences were found, with some features disfavoring less busy centers (e.g., functional class and surgical risk, both p < 0.05), and others suggesting a worse risk profile in those treated in busier institutions (e.g., frailty and history of prior mitral valve intervention, both p < 0.05). Procedural success rates were higher in busier centers (p < 0.001), and hospital stay was also shorter there (p < 0.001). Long-term follow-up (median 14 months) suggested worse outcomes in patients treated in less busy centers at unadjusted analysis (e.g., p = 0.018 for death, p = 0.015 for cardiac death, p = 0.014 for death or hospitalization for heart failure, p < 0.001 for cardiac death or hospitalization for heart failure), even if these associations proved no longer significant after multivariable adjustment, except for cardiac death or hospitalization for heart failure, which appeared significantly less common in the busiest centers (p < 0.05). Similar trends were observed when focusing on tertiles of overall center volume and when comparing for each center the first 50 cases with the following ones. Conclusions: High institutional monthly volume of TEER mitral valve repair appears to correlate with an improved procedural success rate and shorter hospitalizations. Similarly favorable results were found for long-term rates of cardiac death or hospitalization for heart failure. These findings inform on the importance of operator experience and center expertise in achieving state-of-the-art results with TEER, while confirming the usefulness of the proctoring approach when naïve centers begin a TEER program.
- Open Access
- 27 March 2025
- Published by MDPI AG in Preprints.org
Impact of Institutional Monthly Volume of Transcatheter Edge-to-Edge Repair Procedures for Significant Mitral Regurgitation: Evidence from the GIOTTO-VAT Study
Background: Mitral valve transcatheter edge-to-edge repair (TEER) is a widely adopted therapeutic approach for managing significant mitral regurgitation (MR) in high-risk surgical candidates. While procedural safety and efficacy have been demonstrated, the impact of institutional expertise on outcomes remains unclear. We aimed at evaluating whether institutional monthly volume of TEER influences short- and long-term clinical results. Methods: This analysis from the multicenter, prospective GIOTTO trial study evaluated the impact of institutional monthly volume on outcomes of TEER for significant mitral regurgitation. Centers were stratified into tertiles based on monthly volumes (≤2.0 cases/month, 2.1-3.5 cases/month, >3.5 cases/month), and key clinical, echocardiographic, and procedural outcomes were analyzed. Statistical analysis was based on standard bivariate tests as well as unadjusted and multivariable adjusted Cox models. Results: A total of 2,213 patients were included, stratified into tertiles based on institutional procedural volume: 645 (29.1%) patients in the first tertile, 947 (42.8%) patients in the second tertile, and 621 (28.1%) patients in the third tertile. Several baseline differences were found, with some features disfavoring less busy centers (eg functional class and surgical risk, both p< 0.05), and others suggesting a worse risk profile in those treated in busier institutions (eg frailty and history of prior mitral valve intervention, both p< 0.05). Procedural success rates were higher in busier centers (p< 0.001), and hospital stay was also shorter there (p< 0.001). Long-term follow-up (median 14 months) suggested worse outcomes in patients treated in less busy centers at unadjusted analysis (eg p=0.018 for death, p=0.015 for cardiac death, p=0.014 for death or hospitalization for heart failure, p< 0.001 for cardiac death or hospitalization for heart failure), even if these associations proved no longer significant after multivariable adjustment, except for cardiac death or hospitalization for heart failure, which appeared significantly less common in the busiest centers (p< 0.05). Similar trends were observed when focusing on tertiles of overall center volume and when comparing for each center the first 50 cases with the following ones. Conclusion: High institutional monthly volume in TEER mitral valve repair appears to correlate with improved procedural success rate and shorter hospitalizations. Similarly favorable results were found for long-term rates of cardiac death or hospitalization for heart failure. These findings inform on the importance of operator experience and center expertise to achieve state-of-the-art results with TEER, while confirming the usefulness of the proctoring approach when naïve centers begin a TEER program.
- 27 March 2025
- Published by MDPI AG in Preprints.org
Open AccessImpact of Institutional Monthly Volume of Transcatheter Edge-to-Edge Repair Procedures for Significant Mitral Regurgitation: Evidence from the GIOTTO-VAT Study
Background: Mitral valve transcatheter edge-to-edge repair (TEER) is a widely adopted therapeutic approach for managing significant mitral regurgitation (MR) in high-risk surgical candidates. While procedural safety and efficacy have been demonstrated, the impact of institutional expertise on outcomes remains unclear. We aimed at evaluating whether institutional monthly volume of TEER influences short- and long-term clinical results. Methods: This analysis from the multicenter, prospective GIOTTO trial study evaluated the impact of institutional monthly volume on outcomes of TEER for significant mitral regurgitation. Centers were stratified into tertiles based on monthly volumes (≤2.0 cases/month, 2.1-3.5 cases/month, >3.5 cases/month), and key clinical, echocardiographic, and procedural outcomes were analyzed. Statistical analysis was based on standard bivariate tests as well as unadjusted and multivariable adjusted Cox models. Results: A total of 2,213 patients were included, stratified into tertiles based on institutional procedural volume: 645 (29.1%) patients in the first tertile, 947 (42.8%) patients in the second tertile, and 621 (28.1%) patients in the third tertile. Several baseline differences were found, with some features disfavoring less busy centers (eg functional class and surgical risk, both p< 0.05), and others suggesting a worse risk profile in those treated in busier institutions (eg frailty and history of prior mitral valve intervention, both p< 0.05). Procedural success rates were higher in busier centers (p< 0.001), and hospital stay was also shorter there (p< 0.001). Long-term follow-up (median 14 months) suggested worse outcomes in patients treated in less busy centers at unadjusted analysis (eg p=0.018 for death, p=0.015 for cardiac death, p=0.014 for death or hospitalization for heart failure, p< 0.001 for cardiac death or hospitalization for heart failure), even if these associations proved no longer significant after multivariable adjustment, except for cardiac death or hospitalization for heart failure, which appeared significantly less common in the busiest centers (p< 0.05). Similar trends were observed when focusing on tertiles of overall center volume and when comparing for each center the first 50 cases with the following ones. Conclusion: High institutional monthly volume in TEER mitral valve repair appears to correlate with improved procedural success rate and shorter hospitalizations. Similarly favorable results were found for long-term rates of cardiac death or hospitalization for heart failure. These findings inform on the importance of operator experience and center expertise to achieve state-of-the-art results with TEER, while confirming the usefulness of the proctoring approach when naïve centers begin a TEER program.
- Open Access
- 1 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
- Vol. 27 (Supplement) , iii13-iii18
Serious iatrogenic complications: pulmonary vein stenosis after ablation of atrial fibrillation
Pulmonary vein stenosis (PVS) has been recognized as a clinical entity complicating radiofrequency or cryoenergy ablation for atrial fibrillation. Although reduced by technical and procedural advancements, this complication portends remarkable morbidity and presents insidiously with non-specific symptoms causing frequent misdiagnosis and wrong management that lead to detection delay and major adverse implications. Non-invasive imaging is key for timely diagnosis and transcatheter procedural planning. Most recent consensus on severe and symptomatic PVS management indicates that stenting is the preferred treatment because of superior long-term patency compared to balloon angioplasty, particularly in patients with larger reference vessel diameter. However, the rate of recurrent stent restenosis is high and remains a great challenge. Goal of our manuscript is to provide a comprehensive review regarding pathophysiology, detection, treatment, and prevention of this serious iatrogenic complication.
- 1 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
- Vol. 27 (Supplement) , iii13-iii18
Open AccessSerious iatrogenic complications: pulmonary vein stenosis after ablation of atrial fibrillation
Pulmonary vein stenosis (PVS) has been recognized as a clinical entity complicating radiofrequency or cryoenergy ablation for atrial fibrillation. Although reduced by technical and procedural advancements, this complication portends remarkable morbidity and presents insidiously with non-specific symptoms causing frequent misdiagnosis and wrong management that lead to detection delay and major adverse implications. Non-invasive imaging is key for timely diagnosis and transcatheter procedural planning. Most recent consensus on severe and symptomatic PVS management indicates that stenting is the preferred treatment because of superior long-term patency compared to balloon angioplasty, particularly in patients with larger reference vessel diameter. However, the rate of recurrent stent restenosis is high and remains a great challenge. Goal of our manuscript is to provide a comprehensive review regarding pathophysiology, detection, treatment, and prevention of this serious iatrogenic complication.
- Open Access
- 10 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7511
A STEMI Complicated by Cardiogenic Shock Due to Simultaneous Acute Thrombosis of Two Coronary Vessels in the ‘Deadly Double Infarct Syndrome’: A Case Report and Discussion of Literature
Background: ST-segment elevation myocardial infarction (STEMI) remains a leading cause of mortality worldwide, primarily caused by acute thrombosis over atherosclerotic plaques. Simultaneous acute thrombosis in two coronary arteries is an exceptionally rare event. This report highlights a unique case of STEMI associated with cardiogenic shock due to dual coronary artery thrombosis and provides insights from a literature review on this rare condition. Methods: We report the case of a 58-year-old male with a history of hypertension, type II diabetes, and heavy smoking, who presented with a two-day history of chest pain and cardiogenic shock. Diagnostic evaluation included an electrocardiogram showing ST-segment elevation in AVR and ischemia, along with echocardiography revealing severe left ventricular dysfunction (ejection fraction 20%). Emergency coronary angiography was performed to identify the underlying pathology. Additionally, a literature review was conducted to analyze the characteristics and outcomes of similar cases of dual coronary artery thrombosis. Results: Coronary angiography identified significant occlusions in the proximal circumflex branch and the left anterior descending artery (LAD), a combination rarely reported in the literature. Our review confirmed that dual thrombosis involving the LAD and right coronary artery (RCA) is the most frequently described presentation of this condition, while simultaneous CFX and LAD thrombosis is exceedingly rare. Most reported cases, including ours, were associated with cardiogenic shock, highlighting the severity of this clinical entity. Despite successful thrombus aspiration and stenting, our patient experienced severe complications, including infections, pleural effusions, and paralytic ileus, ultimately requiring evaluation for left ventricular assist device implantation. Conclusions: This case underscores the complexity and critical challenges of managing STEMI with cardiogenic shock due to simultaneous coronary thrombosis. The findings from our literature review suggest the need for heightened clinical awareness and tailored revascularization strategies. Further studies are warranted to optimize management approaches and improve outcomes in such rare and high-risk scenarios.
- 10 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7511
Open AccessA STEMI Complicated by Cardiogenic Shock Due to Simultaneous Acute Thrombosis of Two Coronary Vessels in the ‘Deadly Double Infarct Syndrome’: A Case Report and Discussion of Literature
Background: ST-segment elevation myocardial infarction (STEMI) remains a leading cause of mortality worldwide, primarily caused by acute thrombosis over atherosclerotic plaques. Simultaneous acute thrombosis in two coronary arteries is an exceptionally rare event. This report highlights a unique case of STEMI associated with cardiogenic shock due to dual coronary artery thrombosis and provides insights from a literature review on this rare condition. Methods: We report the case of a 58-year-old male with a history of hypertension, type II diabetes, and heavy smoking, who presented with a two-day history of chest pain and cardiogenic shock. Diagnostic evaluation included an electrocardiogram showing ST-segment elevation in AVR and ischemia, along with echocardiography revealing severe left ventricular dysfunction (ejection fraction 20%). Emergency coronary angiography was performed to identify the underlying pathology. Additionally, a literature review was conducted to analyze the characteristics and outcomes of similar cases of dual coronary artery thrombosis. Results: Coronary angiography identified significant occlusions in the proximal circumflex branch and the left anterior descending artery (LAD), a combination rarely reported in the literature. Our review confirmed that dual thrombosis involving the LAD and right coronary artery (RCA) is the most frequently described presentation of this condition, while simultaneous CFX and LAD thrombosis is exceedingly rare. Most reported cases, including ours, were associated with cardiogenic shock, highlighting the severity of this clinical entity. Despite successful thrombus aspiration and stenting, our patient experienced severe complications, including infections, pleural effusions, and paralytic ileus, ultimately requiring evaluation for left ventricular assist device implantation. Conclusions: This case underscores the complexity and critical challenges of managing STEMI with cardiogenic shock due to simultaneous coronary thrombosis. The findings from our literature review suggest the need for heightened clinical awareness and tailored revascularization strategies. Further studies are warranted to optimize management approaches and improve outcomes in such rare and high-risk scenarios.
- Open Access
- 13 November 2024
- Published by MDPI AG in Preprints.org
A STEMI Complicated by Cardiogenic Shock due to Simultaneous Acute Thrombosis of Two Coronary Vessels in the ‘Deadly Double Infarct Syndrome’: A Case Report and Discussion of Literature
Introduction: ST-segment elevation myocardial infarction (STEMI) is a leading cause of death worldwide, commonly caused by acute thrombosis over atherosclerotic plaques. This report presents a rare case of simultaneous acute thrombosis in two coronary arteries, leading to STEMI associated with cardiogenic shock. Case Presentation: A 58-year-old male with a history of hypertension, type II diabetes, and heavy smoking presented with two days of chest pain and was found in cardiogenic shock upon arrival. His ECG showed ST-segment elevation in AVR and ischemia, while echocardiography revealed severe left ventricular dysfunction (EF 20%). Emergency coronary angiography identified significant occlusions in both the proximal circumflex branch and left anterior descending artery (LAD). Despite successful thrombus aspiration and stenting, the patient developed serious complications, including infections, pleural effusions, and paralytic ileus. After nearly two months in the intensive coronary care unit with persistent heart failure, he was referred for evaluation of left ventricular assist device implantation. Conclusion: This case highlights the challenges of managing cardiogenic shock in simultaneous thrombotic events in STEMI, underscoring the need for rapid intervention and tailored management strategies in critically ill patients. Further research is necessary to optimize revascularization approaches and improve outcomes in similar cases.
- 13 November 2024
- Published by MDPI AG in Preprints.org
Open AccessA STEMI Complicated by Cardiogenic Shock due to Simultaneous Acute Thrombosis of Two Coronary Vessels in the ‘Deadly Double Infarct Syndrome’: A Case Report and Discussion of Literature
Introduction: ST-segment elevation myocardial infarction (STEMI) is a leading cause of death worldwide, commonly caused by acute thrombosis over atherosclerotic plaques. This report presents a rare case of simultaneous acute thrombosis in two coronary arteries, leading to STEMI associated with cardiogenic shock. Case Presentation: A 58-year-old male with a history of hypertension, type II diabetes, and heavy smoking presented with two days of chest pain and was found in cardiogenic shock upon arrival. His ECG showed ST-segment elevation in AVR and ischemia, while echocardiography revealed severe left ventricular dysfunction (EF 20%). Emergency coronary angiography identified significant occlusions in both the proximal circumflex branch and left anterior descending artery (LAD). Despite successful thrombus aspiration and stenting, the patient developed serious complications, including infections, pleural effusions, and paralytic ileus. After nearly two months in the intensive coronary care unit with persistent heart failure, he was referred for evaluation of left ventricular assist device implantation. Conclusion: This case highlights the challenges of managing cardiogenic shock in simultaneous thrombotic events in STEMI, underscoring the need for rapid intervention and tailored management strategies in critically ill patients. Further research is necessary to optimize revascularization approaches and improve outcomes in similar cases.
- Open Access
- 16 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4172
Myocardial Ischemia: Differentiating between Epicardial Coronary Artery Atherosclerosis, Microvascular Dysfunction and Vasospasm in the Catheterization Laboratory
Ischemic heart disease is currently the most common cause of mortality and morbidity worldwide. Although myocardial ischemia is classically determined by epicardial coronary atherosclerosis, up to 40% of patients referred for coronary angiography have no obstructive coronary artery disease (CAD). Ischemia with non-obstructive coronary artery disease (INOCA) has typically been underestimated in the past because, until recently, its prognostic significance was not completely clear. This review aims to highlight differences and patterns in myocardial ischemia caused by epicardial obstructive CAD, coronary microvascular dysfunction (CMD) or vasomotor abnormalities and to elucidate the state of the art in correctly diagnosing these different patterns.
- 16 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4172
Open AccessMyocardial Ischemia: Differentiating between Epicardial Coronary Artery Atherosclerosis, Microvascular Dysfunction and Vasospasm in the Catheterization Laboratory
Ischemic heart disease is currently the most common cause of mortality and morbidity worldwide. Although myocardial ischemia is classically determined by epicardial coronary atherosclerosis, up to 40% of patients referred for coronary angiography have no obstructive coronary artery disease (CAD). Ischemia with non-obstructive coronary artery disease (INOCA) has typically been underestimated in the past because, until recently, its prognostic significance was not completely clear. This review aims to highlight differences and patterns in myocardial ischemia caused by epicardial obstructive CAD, coronary microvascular dysfunction (CMD) or vasomotor abnormalities and to elucidate the state of the art in correctly diagnosing these different patterns.
- Open Access
- 17 April 2024
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
- Vol. 26 (Supplement) , i6-i10
I prefer the MitraClip in these cases: the 5-year COAPT data
The COAPT 5-year data demonstrate that compared with medical treatment transcatheter edge-to-edge repair (TEER) with the MitraClip in symptomatic patients with Grade 3+/Grade 4+ secondary mitral regurgitation (SMR) reduced by nearly half the annualized hospitalization risk (33 vs. 57%), by almost 30% the death rate (57 vs. 67%) and achieved significant and durable SMR reduction in 95% of patients. Control patients who crossed over to TEER at 2 years had better prognosis, but nearly half of them died before reaching crossover eligibility. Death or hospitalization for heart failure (HHF) occurred in 73.6% of TEER patients and 91.5% of controls within 5 years, pointing to a need for further study to address left ventricle (LV) dysfunction, the underlying cause of patient’s disease. MTRA-FR targeted SMR using the same device and did not improve the composite endpoint of all-cause mortality or HHF at 12 months. Possible reasons for the discrepancy include enrolment of patients with more severe MR and less-advanced LV disease (dilation/dysfunction), less-procedural complications, and higher success in reducing MR in COAPT compared with MITRA-FR. Thus, the ideal patient for MitraClip treatment would be one with severe MR, but with no too severe LV dilation/dysfunction, which is what differentiates COAPT patients from those in MITRA-FR.
- 17 April 2024
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
- Vol. 26 (Supplement) , i6-i10
Open AccessI prefer the MitraClip in these cases: the 5-year COAPT data
The COAPT 5-year data demonstrate that compared with medical treatment transcatheter edge-to-edge repair (TEER) with the MitraClip in symptomatic patients with Grade 3+/Grade 4+ secondary mitral regurgitation (SMR) reduced by nearly half the annualized hospitalization risk (33 vs. 57%), by almost 30% the death rate (57 vs. 67%) and achieved significant and durable SMR reduction in 95% of patients. Control patients who crossed over to TEER at 2 years had better prognosis, but nearly half of them died before reaching crossover eligibility. Death or hospitalization for heart failure (HHF) occurred in 73.6% of TEER patients and 91.5% of controls within 5 years, pointing to a need for further study to address left ventricle (LV) dysfunction, the underlying cause of patient’s disease. MTRA-FR targeted SMR using the same device and did not improve the composite endpoint of all-cause mortality or HHF at 12 months. Possible reasons for the discrepancy include enrolment of patients with more severe MR and less-advanced LV disease (dilation/dysfunction), less-procedural complications, and higher success in reducing MR in COAPT compared with MITRA-FR. Thus, the ideal patient for MitraClip treatment would be one with severe MR, but with no too severe LV dilation/dysfunction, which is what differentiates COAPT patients from those in MITRA-FR.
- Open Access
- 15 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (22) , 7121
Contemporary Echocardiographic Evaluation of Mitral Regurgitation and Guidance for Percutaneous Mitral Valve Repair
Mitral valve regurgitation (MR) is a multifaceted valvular heart disease. Echocardiography plays a central role in etiology assessment, severity quantification, treatment candidacy, outcome evaluation, and patient follow-up. In this review, we describe the comprehensive echocardiographic assessment of MR, including transthoracic (TTE) and transesophageal (TEE) approaches, 2D and 3D modalities, strain imaging, stress echocardiography, and artificial intelligence (AI) applications. Transcatheter edge-to-edge mitral valve repair (TEER) has been established as a key therapy for patients with severe, symptomatic MR and high surgical risk. TEER is performed under TEE guidance. We outline a practical overview of echocardiographic guidance on TEER.
- 15 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (22) , 7121
Open AccessContemporary Echocardiographic Evaluation of Mitral Regurgitation and Guidance for Percutaneous Mitral Valve Repair
Mitral valve regurgitation (MR) is a multifaceted valvular heart disease. Echocardiography plays a central role in etiology assessment, severity quantification, treatment candidacy, outcome evaluation, and patient follow-up. In this review, we describe the comprehensive echocardiographic assessment of MR, including transthoracic (TTE) and transesophageal (TEE) approaches, 2D and 3D modalities, strain imaging, stress echocardiography, and artificial intelligence (AI) applications. Transcatheter edge-to-edge mitral valve repair (TEER) has been established as a key therapy for patients with severe, symptomatic MR and high surgical risk. TEER is performed under TEE guidance. We outline a practical overview of echocardiographic guidance on TEER.
- 1 August 2023
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 19 (6) , 459-461
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 August 2023
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 19 (6) , 459-461
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)